Home > NRC Library > ADAMS Public Documents

06-27843-02 608976 Bristol-Myers Squibb PRI

Accession Number: ML18157A104

Date Released: Thursday, July 5, 2018

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML18157A105 - Bristol-Myers Squibb PRI, e-mails dated May 30, 2018 and May 31, 2018 w/Amendment Request Ltr. Dated May 31, 2018 with the Decontamination and Decommissioning Plan dated May 22, 2018. (31 page(s), 5/31/2018)
• ML18158A224 - Bristol-Myers Squibb PRI, Request for Additional Information Ltr. Dated June 06, 2018. (1 page(s), 6/6/2018)
• ML18164A328 - Bristol-Myers Squibb PRI, E-mail dtd June 08, 2018, Rec'd. in LAT 06/11/2018, RE: Deficiency Response, Control No. 608976. (3 page(s), 6/8/2018)
• ML18178A443 - Bristol-Myers Squibb Company, Cover Letter dtd June 14, 2018, for License Amendment No. 23, Control No. 608976. (3 page(s), 6/14/2018)
• ML18178A445 - Bristol-Myers Squibb Company, License Amendment No. 23, Control No. 608976. (5 page(s), 6/14/2018)